This result is consistent with previous reports in the literature that identify Ang2 as a pathogenic regulator in the response to hyperoxia [29, 44] and a potential biomarker denoting increased risk for BPD [45, 46]. Here, ANGPT2 is linked to bronchopulmonary dysplasia.